Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company, Announces Closing of $50 Million Series A Financing ...Middle East

Proceeds to fund development of novel and best-in-class therapeutics for eye diseases Charles Semba, MD, joins the company to serve as Chief Medical Officer SHANGHAI, Nov. 27, 2020 /PRNewswire/ -- Eluminex Biosciences Limited (Eluminex), an ophthalmic biotechnology company committed to...

Hence then, the article about eluminex biosciences an ophthalmology focused biotechnology company announces closing of 50 million series a financing was published today ( Friday 27/11/2020 - 04:30 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Eluminex Biosciences, an Ophthalmology-Focused Biotechnology Company, Announces Closing of $50 Million Series A Financing )

Also on site :

• Meta buys robotic startup to bolster its humanoid AI ambitions
• Psychologist Says if You Can Never Sit Still During Phone Conversations, You Likely Have These 9 Traits
• LIV Golf’s Days Might Be Numbered. What Does That Mean for the Sport? – Stroman on Sports (May 1, 2026)